Malignant Reproductive System Neoplasm — Trials

Malignant Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,803
Recruiting: 1,544
Ph III recruiting: 175
Growth YoY: +16.5%
Industry share: 21%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,473)

clinicaltrialsPublishedShowing 101–123 of 123 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00002976	Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer	terminated	Phase 3	2,108	Gynecologic Oncology GroupNETWORK	1	Apr 11, 2013	clinicaltrials
NCT00016341	Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer	terminated	Phase 3	—	Gynecologic Oncology GroupNETWORK	2	Apr 11, 2013	clinicaltrials